Because all types of fibroblasts employed in the proliferation tests were considered to be activated, with α-SMA and FAP expression [1], [17], we suspect that the activation of the fibroblasts but not necessarily the origin of the fibroblasts accounted for the increase in HCC proliferation. The gene discussed is FAP; the disease is hepatocellular carcinoma.